Unichem Laboratories Limited (NSE:UNICHEMLAB)

Market Cap	35.63B +9.9%
Revenue (ttm)	23.72B +6.6%
Net Income	3.39B +283.1%
EPS	47.98 +282.2%
Shares Out	n/a
PE Ratio	10.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,432
Open	510.00
Previous Close	509.15
Day's Range	501.10 - 511.80
52-Week Range	278.20 - 687.20
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About Unichem Laboratories

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, formulations, bu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1944
• Employees: 2,780
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: UNICHEMLAB

Financial Performance

In fiscal year 2026, Unichem Laboratories's revenue was 22.02 billion, an increase of 4.31% compared to the previous year's 21.11 billion. Earnings were 2.53 billion, an increase of 83.86%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error